← All indications
Antibodies, Monoclonal, Humanized
Antibodies from non-human species whose protein sequences have been modified to make them nearly identical with human antibodies. If the constant region and part of the variable region are replaced, they are called humanized. If only the constant region is modified they are called chimeric. INN names for humanized antibodies end in -zumab.
Subtype terms (22)
More specific conditions that are subtypes of Antibodies, Monoclonal, Humanized in the MeSH hierarchy.
- Abciximab
- Adalimumab
3 drugs (2 approved, 1 experimental)
- Alemtuzumab
1 drug approved
- Basiliximab
- Bevacizumab
26 drugs (16 approved, 10 experimental)
- Brentuximab Vedotin
9 drugs approved
- Certolizumab Pegol
- Cetuximab
9 drugs (6 approved, 3 experimental)
- Daclizumab
- Denosumab
4 drugs approved
- Gemtuzumab
- Inotuzumab Ozogamicin
2 drugs approved
- Ipilimumab
- Natalizumab
- Nivolumab
6 drugs (4 approved, 2 experimental)
- Omalizumab
1 drug approved
- Palivizumab
- Panitumumab
- Ramucirumab
- Ranibizumab
1 drug approved
- Trastuzumab
3 drugs approved
- Ustekinumab